Short-term hemostatic safety of strontium ranelate treatment in elderly women with osteoporosis

HALİL M. G., Cankurtaran M., DOĞU B. B., Ulger Z., Piskinpasa S., Gedik A., ...Daha Fazla

ANNALS OF PHARMACOTHERAPY, cilt.41, sa.1, ss.41-45, 2007 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 41 Sayı: 1
  • Basım Tarihi: 2007
  • Doi Numarası: 10.1345/aph.1h506
  • Dergi Adı: ANNALS OF PHARMACOTHERAPY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.41-45
  • Hacettepe Üniversitesi Adresli: Evet

Özet

BACKGROUND: Strontium ranelate offers significant clinical terms of efficacy, tolerability, and ease of administration in the treatment of postmenopausal osteoporosis. However, there are some data revealing an association between strontium ranelate treatment and increased incidence of venous thromboembolism (VTE), suggesting possible adverse prothrombotic effects of the drug.